DATS sensitizes glioma cells to TRAIL-mediated apoptosis by up-regulation of death receptor 5 via ROS
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Jung Soon | - |
dc.contributor.author | Lee, Yong Yook | - |
dc.contributor.author | Lee, Dae-Hee | - |
dc.contributor.author | Kwon, Ki Han | - |
dc.date.accessioned | 2021-09-03T03:36:33Z | - |
dc.date.available | 2021-09-03T03:36:33Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2017-08 | - |
dc.identifier.issn | 0278-6915 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/82737 | - |
dc.description.abstract | Tumor necrosis factor-related apoptosis-induced ligand (TRAIL) is a promising anticancer reagent for antitumor therapy. However, many cancer cells, including malignant glioma cells, tend to be resistant to TRAIL, due to repeat treat to cancer cells, highlighting the need for strategies to overcome TRAIL resistance. Here we present that in combination with diallyl trisulfide (DATS), exposure to TRAIL induced apoptosis in TRAIL-resistant glioma cells. Surprisingly, we found that subtoxic concentrations of DATS significantly potentiated TRAIL-induced cytotoxicity and apoptosis in glioma cells. DATS dramatically upregulated DR5 receptor expression but had no effects on DR4 receptor. In addition, DATS enhances TRAIL-induced apoptosis through the downregulation of anti-apoptotic protein (Mcl-1) and the upregulation of DR5 receptors through actions on the ROS-induced-p53. (C) 2017 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | HUMAN PROSTATE-CANCER | - |
dc.subject | SIGNALING PATHWAYS | - |
dc.subject | DIALLYL TRISULFIDE | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | LEUKEMIA CELLS | - |
dc.subject | EXPRESSION | - |
dc.subject | P53 | - |
dc.subject | ANTICANCER | - |
dc.subject | GENERATION | - |
dc.subject | INHIBITION | - |
dc.title | DATS sensitizes glioma cells to TRAIL-mediated apoptosis by up-regulation of death receptor 5 via ROS | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Dae-Hee | - |
dc.identifier.doi | 10.1016/j.fct.2017.05.056 | - |
dc.identifier.scopusid | 2-s2.0-85021086665 | - |
dc.identifier.wosid | 000405160600052 | - |
dc.identifier.bibliographicCitation | FOOD AND CHEMICAL TOXICOLOGY, v.106, pp.514 - 521 | - |
dc.relation.isPartOf | FOOD AND CHEMICAL TOXICOLOGY | - |
dc.citation.title | FOOD AND CHEMICAL TOXICOLOGY | - |
dc.citation.volume | 106 | - |
dc.citation.startPage | 514 | - |
dc.citation.endPage | 521 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Food Science & Technology | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Food Science & Technology | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | HUMAN PROSTATE-CANCER | - |
dc.subject.keywordPlus | SIGNALING PATHWAYS | - |
dc.subject.keywordPlus | DIALLYL TRISULFIDE | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | LEUKEMIA CELLS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | P53 | - |
dc.subject.keywordPlus | ANTICANCER | - |
dc.subject.keywordPlus | GENERATION | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordAuthor | DATS | - |
dc.subject.keywordAuthor | TRAIL | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | ROS | - |
dc.subject.keywordAuthor | p53 | - |
dc.subject.keywordAuthor | DR5 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.